omega-n-methylarginine has been researched along with pancreastatin in 2 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (pancreastatin) | Trials (pancreastatin) | Recent Studies (post-2010) (pancreastatin) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 277 | 4 | 36 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Yanes, C; Najib, S; Sánchez-Margalet, V | 1 |
Díaz-Troya, S; Najib, S; Sánchez-Margalet, V | 1 |
2 other study(ies) available for omega-n-methylarginine and pancreastatin
Article | Year |
---|---|
Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells.
Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Chromogranin A; Chromogranins; Cyclic GMP; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Liver Neoplasms; Nitric Oxide; omega-N-Methylarginine; Pancreatic Hormones; Protein Synthesis Inhibitors; Rats; Tumor Cells, Cultured | 2001 |
eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Topics: Aminoquinolines; Animals; Arginine; Calcium; Carbazoles; Carcinoma, Hepatocellular; Cell Enlargement; Cell Proliferation; Chromogranin A; Chromogranins; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA; Enzyme Inhibitors; Guanylate Cyclase; Indoles; Isoenzymes; Leucine; Liver; MAP Kinase Signaling System; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Ornithine; Pancreatic Hormones; Peptides; Phospholipase C beta; Protein Isoforms; Rats; Receptors, Atrial Natriuretic Factor; Spermidine; Thymidine; Time Factors; Type C Phospholipases | 2005 |